Related Experiment Video
Updated: Oct 5, 2025

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
Published on: July 29, 2014
AMPK-autophagy-mediated inhibition of microRNA-30a-5p alleviates morphine tolerance via SOCS3-dependent
Li Wan1, Ru-Meng Jia1, Lu-Lu Ji1
1Jiangsu Key Laboratory of Neurodegeneration, Department of Pharmacology, Nanjing Medical University, Nanjing, 211166, Jiangsu, China.
Background:
The development of morphine tolerance is a clinical challenge for managing severe pain. Studies have shown that neuroinflammation is a critical aspect for the development of analgesic tolerance. We found that AMPK-autophagy activation could suppress neuroinflammation and improve morphine tolerance via the upregulation of suppressor of cytokine signaling 3 (SOCS3) by inhibiting the processing and maturation of microRNA-30a-5p.
Methods:
CD-1 mice were utilized for the tail-flick test to evaluate morphine tolerance. The microglial cell line BV-2 was utilized to investigate the mechanism of AMPK-autophagy-mediated posttranscriptional regulation of SOCS3. Proinflammatory cytokines were measured by western blotting and real-time PCR. The levels of SOCS3 and miRNA-processing enzymes were evaluated by western blotting, real-time PCR and immunofluorescence staining.
Results:
Based on experimental verification, miRNA-30a-5p could negatively regulate SOCS3. The AMPK activators AICAR, resveratrol and metformin downregulated miRNA-30a-5p. We found that AMPK activators specifically inhibited the processing and maturation of miRNA-30a-5p in microglia by degrading DICER and AGO2 via autophagy. Furthermore, a miRNA-30a-5p inhibitor significantly improved morphine tolerance via upregulation of SCOS3 in mice. It markedly increased the level of SOCS3 in the spinal cord of mice and subsequently inhibited morphine-induced phosphorylation of NF-κB p65. In addition, a miRNA-30a-5p inhibitor decreased the levels of IL-1β and TNF-α caused by morphine in microglia.
Conclusion:
AMPK-autophagy activation suppresses neuroinflammation and improves morphine tolerance via the upregulation of SOCS3 by inhibiting miRNA-30a-5p.
Insights
AMPK-autophagy activation suppresses neuroinflammation and improves morphine tolerance by upregulating SOCS3 through inhibiting microRNA-30a-5p processing. This finding offers a novel therapeutic strategy for managing pain and opioid tolerance.
Area of Science:
- Neuroscience
- Pharmacology
- Molecular Biology
Background:
- Morphine tolerance, a significant clinical issue in pain management, is closely linked to neuroinflammation.
- AMPK-autophagy activation has emerged as a potential modulator of analgesic tolerance.
Purpose of the Study:
- To investigate the role of AMPK-autophagy in suppressing neuroinflammation and enhancing morphine efficacy.
- To elucidate the underlying molecular mechanism involving suppressor of cytokine signaling 3 (SOCS3) and microRNA-30a-5p.
Main Methods:
- Morphine tolerance was assessed in CD-1 mice using the tail-flick test.
- Microglial cell line BV-2 was used to study the posttranscriptional regulation of SOCS3.
- Western blotting, real-time PCR, and immunofluorescence staining were employed to measure cytokine levels, SOCS3, and miRNA-processing enzymes.
Main Results:
- MicroRNA-30a-5p was identified as a negative regulator of SOCS3.
- AMPK activators (AICAR, resveratrol, metformin) downregulated microRNA-30a-5p by inhibiting its processing and maturation via autophagy-mediated degradation of DICER and AGO2.
- Inhibition of microRNA-30a-5p significantly improved morphine tolerance, upregulated SOCS3, and reduced neuroinflammation markers (IL-1β, TNF-α) in mice and microglia.
Conclusions:
- AMPK-autophagy activation effectively suppresses neuroinflammation and ameliorates morphine tolerance.
- This beneficial effect is mediated by the upregulation of SOCS3 through the inhibition of microRNA-30a-5p processing and maturation.
- Targeting the AMPK-autophagy-SOCS3-microRNA-30a-5p pathway presents a promising therapeutic avenue for managing pain and opioid tolerance.
More Related Videos
07:05Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents
Published on: September 10, 2018
09:54Combining Laser Capture Microdissection and Microfluidic qPCR to Analyze Transcriptional Profiles of Single Cells: A Systems Biology Approach to Opioid Dependence
Published on: March 8, 2020
Related Concept Videos
Analgesia and Pain Management
Opioid Receptors: Overview
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Opioid Analgesics: Morphine and Other Natural Cogeners
MicroRNAs
Desensitization and Tachyphylaxis